Lifestyle factors in multiple sclerosis disability progression and silent brain damage: A cross-sectional study

被引:13
作者
Van Hijfte, Liesbeth [1 ]
Loret, Griet [1 ]
Bachmann, Helen [1 ]
Reynders, Tatjana [2 ]
Breuls, Marleen [2 ]
Deschepper, Ellen [3 ]
Kuhle, Jens [4 ,5 ,6 ]
Willekens, Barbara [2 ,7 ,8 ]
Laureys, Guy [1 ]
机构
[1] Ghent Univ Hosp, Inst Neurosci, Dept Neurol, 4Brain, C Heymanslaan 10,route 1525, B-9000 Ghent, Belgium
[2] Antwerp Univ Hosp, Dept Neurol, Edegem, Belgium
[3] Univ Ghent, Biostat Unit, Ghent, Belgium
[4] Univ Basel, Univ Hosp Basel, Dept Med, Neurol Clin & Policlin, Basel, Switzerland
[5] Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland
[6] Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel, Switzerland
[7] Univ Antwerp, Fac Med & Hlth Sci, Translat Neurosci Res Grp, Antwerp, Belgium
[8] Univ Antwerp, Fac Med & Hlth Sci, Lab Expt Hematol, Antwerp, Belgium
关键词
Multiple sclerosis; Disability progression; Lifestyle factors; Neurofilament; PHYSICAL-ACTIVITY; COGNITIVE RESERVE; HEALTH-BENEFITS; INSIGHTS; DISEASE; SCORE;
D O I
10.1016/j.msard.2022.104016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the association between lifestyle risk factors with 1/ the Multiple Sclerosis Severity Score (MSSS) and 2/ ongoing subclinical brain damage in non-active MS patients on high-efficacy treatment. Methods: Cross-sectional study in persons with Multiple Sclerosis (PwMS) investigating lifestyle factors including cognitive reserve (CR), physical activity (PA), smoking status, alcohol use, dietary habits, body mass index (BMI), blood pressure (BP) and cholesterol ratio. Data were collected through validated questionnaires, clinical and laboratory examination. Serum Neurofilament light chain (sNfL) levels were used as a proxy for ongoing brain damage in a subgroup of persons with non-active MS on high-efficacy treatment. Multiple regression analysis (MRA) models explored the relationship between lifestyle factors with the MSSS score and sNfL. Results: 351 PwMS were included (43.04 +/- 11.77 years, 69.8% female). Higher CR and PA were associated with a lower MSSS; overweight or obesity and higher systolic BP with a higher MSSS. The MRA model explained 22.2% of the variance for MSSS (R-2.255, adjusted R-2.222). Higher BMI and BP were related to lower sNfL. Twenty-3% (R-2.279, adjusted R-2.230) of the variance was explained in the MRA model for sNfL. Conclusion: Our study suggests an association between a 'brain healthy lifestyle' with disability progression in MS. A cognitive and physical active lifestyle alongside a normal body weight and blood pressure may help to prevent future disability in MS. Longitudinal and interventional research is necessary to gain insight in the causal pathway of these risk factors in preventing disability progression in MS.
引用
收藏
页数:8
相关论文
共 48 条
  • [1] Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors
    Amato, Maria Pia
    Prestipino, Elio
    Bellinvia, Angelo
    Niccolai, Claudia
    Razzolini, Lorenzo
    Pasto, Luisa
    Fratangelo, Roberto
    Tudisco, Laura
    Fonderico, Mattia
    Mattiolo, Paolo Luca
    Goretti, Benedetta
    Zimatore, Giovanni Bosco
    Losignore, Nunzia Alessandra
    Portaccio, Emilio
    Lolli, Francesco
    [J]. PLOS ONE, 2019, 14 (10):
  • [2] The role of cognitive reserve in multiple sclerosis: A cross-sectional study in 526 patients
    Artemiadis, Artemios
    Bakirtzis, Christos
    Ifantopoulou, Parthena
    Zis, Panagiotis
    Bargiotas, Panagiotis
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [3] What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models
    Babyak, MA
    [J]. PSYCHOSOMATIC MEDICINE, 2004, 66 (03): : 411 - 421
  • [4] Increasing Physical Activity and Participation in People With Multiple Sclerosis: A Review
    Backus, Deborah
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2016, 97 (09): : S210 - S217
  • [5] Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
    Barro, Christian
    Benkert, Pascal
    Disanto, Giulio
    Tsagkas, Charidimos
    Amann, Michael
    Naegelin, Yvonne
    Leppert, David
    Gobbi, Claudio
    Granziera, Cristina
    Yaldizli, Ozgur
    Michalak, Zuzanna
    Wuerfel, Jens
    Kappos, Ludwig
    Parmar, Katrin
    Kuhle, Jens
    [J]. BRAIN, 2018, 141 : 2382 - 2391
  • [6] Benkert P, 2020, AMERICAS COMMITTEE T
  • [7] Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis
    Brandstadter, Rachel
    Sand, Ilana Katz
    Sumowski, James F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (10) : 1372 - 1378
  • [8] Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis
    Bridel, Claire
    Leurs, Cyra E.
    van Lierop, Zoe Y. G. J.
    van Kempen, Zoe L. E.
    Dekker, Iris
    Twaalfhoven, Harry A. M.
    Moraal, Bastiaan
    Barkhof, Frederik
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    Teunissen, Charlotte E.
    [J]. NEUROLOGY, 2021, 97 (19) : E1898 - E1905
  • [9] Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
    Brown, J. William L.
    Coles, Alasdair
    Horakova, Dana
    Havrdova, Eva
    Izquierdo, Guillermo
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Trojano, Maria
    Lugaresi, Alessandra
    Bergamaschi, Roberto
    Grammond, Pierre
    Alroughani, Raed
    Hupperts, Raymond
    McCombe, Pamela
    Van Pesch, Vincent
    Sola, Patrizia
    Ferraro, Diana
    Grand'Maison, Francois
    Terzi, Murat
    Lechner-Scott, Jeannette
    Flechter, Schlomo
    Slee, Mark
    Shaygannejad, Vahid
    Pucci, Eugenio
    Granella, Franco
    Jokubaitis, Vilija
    Willis, Mark
    Rice, Claire
    Scolding, Neil
    Wilkins, Alastair
    Pearson, Owen R.
    Ziemssen, Tjalf
    Hutchinson, Michael
    Harding, Katharine
    Jones, Joanne
    McGuigan, Christopher
    Butzkueven, Helmut
    Kalincik, Tomas
    Robertson, Neil
    Onofrj, Marco
    De Luca, Giovanna
    Di Tommaso, Valeria
    Travaglini, Daniela
    Pietrolongo, Erika
    di Ioia, Maria
    Farina, Deborah
    Mancinelli, Luca
    Hodgkinson, Suzanne
    Oreja-Guevara, Celia
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (02): : 175 - 187
  • [10] Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
    Chataway, Jeremy
    Schuerer, Nadine
    Alsanousi, Ali
    Chan, Dennis
    MacManus, David
    Hunter, Kelvin
    Anderson, Val
    Bangham, Charles R. M.
    Clegg, Shona
    Nielsen, Casper
    Fox, Nick C.
    Wilkie, David
    Nicholas, Jennifer M.
    Calder, Virginia L.
    Greenwood, John
    Frost, Chris
    Nicholas, Richard
    [J]. LANCET, 2014, 383 (9936) : 2213 - 2221